About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

NovoTTF System for Glioblastoma Tumors

by Savitha C Muppala on March 20, 2011 at 12:54 PM
Font : A-A+

 NovoTTF System for Glioblastoma Tumors

NovoTTF system for glioblastoma tumors is capable of giving electric currents to disrupt tumor cells before they divide. FDA is yet to give the final approval for its use on patients with glioblastoma tumors.

U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel is of the opinion that the risks of using the NovoTTF-100A System (NovoTTF) is reduced when it is administered as monotherapy instead of standard medical therapy.

Advertisement

A randomized phase III trial for 237 patients with glioblastoma tumors showed that patients treated with the NovoTTF were benefited with better survival time than patients treated with chemotherapy. NovoTTF treated patients also said that they had better quality of life and lesser side effects compared to those treated with chemo.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Glioblastoma Multiforme 

Most Popular on Medindia

How to Reduce School Bag Weight - Simple Tips Blood Donation - Recipients A-Z Drug Brands in India Drug Side Effects Calculator Noscaphene (Noscapine) Sanatogen Hearing Loss Calculator Selfie Addiction Calculator The Essence of Yoga Post-Nasal Drip
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

NovoTTF System for Glioblastoma Tumors Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests